MaxLinear (NASDAQ: MXL) grants stock and 14,219 RSUs to executive

Rhea-AI Filing Summary

MaxLinear, Inc. Corporate Controller & PAO Connie H. Kwong reported equity awards in the form of common stock and restricted stock units. On February 20, 2026, she acquired 9,231 shares of common stock under the company’s Executive Incentive Bonus Plan for the 2025 performance period, and 1,702 additional shares tied to 2025 financial performance conditions, with both issuances made under the Amended and Restated 2010 Equity Incentive Plan. On February 18, 2026, she received 14,219 restricted stock units, each representing one share of common stock, vesting in three equal annual installments starting May 20, 2027 and becoming fully vested on May 20, 2029, contingent on continued service.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kwong Connie H.

(Last) (First) (Middle)

C/O MAXLINEAR, INC.

5966 LA PLACE COURT, SUITE 100

(Street)

CARLSBAD CA 92008

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MAXLINEAR, INC [ MXL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Corporate Controller & PAO

3. Date of Earliest Transaction (Month/Day/Year)
02/18/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/20/2026		A		9,231(1)	A	$0	67,383	D
Common Stock	02/20/2026		A		1,702(2)	A	$0	69,085	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(3)	02/18/2026		A		14,219		(4)	(4)	Common Stock	14,219	$0	14,219	D

Explanation of Responses:

1. Represents shares of Common Stock issued to the Reporting Person for the 2025 performance period under the Company's Executive Incentive Bonus Plan (the "Bonus Plan"). All shares were issued pursuant to the Company's Amended and Restated 2010 Equity Incentive Plan. Grant amounts were determined based on the award amount earned under the Bonus Plan and the closing price of the Company's Common Stock in trading on The Nasdaq Global Select Market on February 20, 2026.

2. Represents shares of Common Stock issued to the Reporting Person in connection with the achievement of financial performance conditions for the 2025 fiscal year that were approved as part of the 2025 performance-based restricted stock award granted on August 4, 2025. All shares were issued pursuant to the Company's Amended and Restated 2010 Equity Incentive Plan.

3. Each restricted stock unit ("RSU") represents a contingent right to receive one share of MaxLinear, Inc. Common Stock.

4. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Company's Amended and Restated 2010 Equity Incentive Plan) through each applicable vesting date, one-third (1/3rd) of the RSUs subject to the award will vest on May 20, 2027, and one-third (1/3rd) of the RSUs subject to the award will vest annually on each May 20 thereafter, such that the award will be fully vested on May 20, 2029.

Remarks:

	/s/ Connie Kwong	02/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did MaxLinear (MXL) report for Connie H. Kwong?

MaxLinear reported that Corporate Controller & PAO Connie H. Kwong received common stock and RSU awards. She acquired shares for 2025 performance and 2025 financial goals, plus 14,219 RSUs, all under the company’s Amended and Restated 2010 Equity Incentive Plan.

How many MaxLinear (MXL) common shares did Connie H. Kwong acquire?

Connie H. Kwong acquired 9,231 common shares for the 2025 performance period and 1,702 common shares linked to 2025 financial performance. Both issuances were made under MaxLinear’s Amended and Restated 2010 Equity Incentive Plan as part of executive performance-based compensation.

What restricted stock unit grant did MaxLinear (MXL) award to Connie H. Kwong?

MaxLinear granted Connie H. Kwong 14,219 restricted stock units on February 18, 2026. Each RSU represents a contingent right to receive one share of common stock, subject to a multi-year vesting schedule and her continued service with the company through each vesting date.

How do Connie H. Kwong’s MaxLinear (MXL) RSUs vest over time?

One-third of Connie H. Kwong’s 14,219 RSUs vest on May 20, 2027, with another one-third vesting on each May 20 thereafter. The award becomes fully vested on May 20, 2029, provided she continues as a service provider through each vesting date.

Under which plans were the MaxLinear (MXL) stock awards to Connie H. Kwong issued?

The stock awards were issued under MaxLinear’s Amended and Restated 2010 Equity Incentive Plan. The 9,231-share grant came via the Executive Incentive Bonus Plan, and the 1,702-share grant related to 2025 performance-based restricted stock approved for that fiscal year.

What performance periods do Connie H. Kwong’s MaxLinear (MXL) stock awards relate to?

The 9,231-share award corresponds to the 2025 performance period under the Executive Incentive Bonus Plan. The 1,702-share award is tied to achievement of financial performance conditions for the 2025 fiscal year that were part of a 2025 performance-based restricted stock grant.